LEVIN CAPITAL STRATEGIES, L.P.
Position in SPRY — ARS Pharmaceuticals, Inc.
CIK 1354821
NEW YORK, NY
Position in SPRY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,437,064
-$4,271,380 QoQ
Shares Held
552,561
-26.1% QoQ
Ownership
0.556%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 80%
None 20%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Derivatives in SPRY
reported options exposure · as of Jun 30, 2025CallValue
$130,875
CallShares
7,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LEVIN CAPITAL STRATEGIES, L.P. holds $12,744,736 across 8 Biotechnology names. SPRY ranks #2 (34.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AURA |
Aura Biosciences, Inc.
|
941,400 | $6,297,966 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
552,561 | $4,437,064 | |
| 3 | DRTS |
Alpha Tau Medical Ltd.
|
106,423 | $752,410 | |
| 4 | SMMT |
Summit Therapeutics Inc.
|
37,676 | $714,336 | |
| 5 | EYPT |
EyePoint, Inc.
|
31,500 | $406,035 | |
| 6 | IMRX |
Immuneering Corp
|
10,000 | $52,700 | |
| 7 | PRME |
Prime Medicine, Inc.
|
15,000 | $52,200 | |
| 8 | ALLO |
Allogene Therapeutics, Inc.
|
13,125 | $32,025 |
All Filings in SPRY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,437,064 | 552,561 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $8,708,444 | 747,506 | Shares | Other | 2026-01-30 | |
| 2025-09-30 | $7,681,154 | 764,294 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $130,875 | 7,500 | Call | Other | 2025-08-05 | |
| 2025-06-30 | $5,045,615 | 289,147 | Shares | Other | 2025-08-05 | |
| 2025-03-31 | $14,650,680 | 1,164,601 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $4,933,464 | 467,627 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $435,000 | 30,000 | Call | Other | 2024-11-13 | |
| 2024-09-30 | $3,906,677 | 269,426 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $708,457 | 83,250 | Shares | Other | 2024-08-07 | |
| 2024-06-30 | $340,400 | 40,000 | Call | Other | 2024-08-07 | |
| 2024-03-31 | $564,655 | 55,250 | Shares | Other | 2024-05-16 | |
| 2023-12-31 | $286,330 | 52,250 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $264,600 | 70,000 | Call | Other | 2023-10-31 | |
| 2023-09-30 | $241,920 | 64,000 | Shares | Other | 2023-10-31 | |
| 2023-06-30 | $1,132,795 | 169,074 | Shares | Other | 2023-07-31 | |
| 2023-03-31 | $913,685 | 140,351 | Shares | Other | 2023-04-24 | |
| 2022-12-31 | $332,755 | 39,010 | Shares | Other | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||